Ocumension Therapeutics (HKG:1477)

Ocumension Therapeutics Statistics

Total Valuation

HKG:1477 has a market cap or net worth of HKD 5.98 billion. The enterprise value is 5.74 billion.

Market Cap	5.98B
Enterprise Value	5.74B

Important Dates

The last earnings date was Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:1477 has 815.38 million shares outstanding. The number of shares has increased by 16.13% in one year.

Current Share Class	815.38M
Shares Outstanding	815.38M
Shares Change (YoY)	+16.13%
Shares Change (QoQ)	+11.42%
Owned by Insiders (%)	16.43%
Owned by Institutions (%)	7.88%
Float	297.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	92.41
PS Ratio	6.68
PB Ratio	1.46
P/TBV Ratio	4.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-32.46
EV / Sales	6.41
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.70, with a Debt / Equity ratio of 0.05.

Current Ratio	3.70
Quick Ratio	2.89
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-65.52

Financial Efficiency

Return on equity (ROE) is -4.26% and return on invested capital (ROIC) is -2.61%.

Return on Equity (ROE)	-4.26%
Return on Assets (ROA)	-2.48%
Return on Invested Capital (ROIC)	-2.61%
Return on Capital Employed (ROCE)	-4.18%
Weighted Average Cost of Capital (WACC)	6.92%
Revenue Per Employee	1.77M
Profits Per Employee	-349,973
Employee Count	505
Asset Turnover	0.20
Inventory Turnover	8.10

Taxes

In the past 12 months, HKG:1477 has paid 389,484 in taxes.

Income Tax	389,484
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +50.62% in the last 52 weeks. The beta is 0.52, so HKG:1477's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	+50.62%
50-Day Moving Average	7.10
200-Day Moving Average	8.54
Relative Strength Index (RSI)	56.85
Average Volume (20 Days)	913,675

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1477 had revenue of HKD 895.09 million and -176.74 million in losses. Loss per share was -0.22.

Revenue	895.09M
Gross Profit	401.64M
Operating Income	-178.28M
Pretax Income	-176.35M
Net Income	-176.74M
EBITDA	-92.52M
EBIT	-178.28M
Loss Per Share	-0.22

Balance Sheet

The company has 447.86 million in cash and 208.69 million in debt, with a net cash position of 239.17 million or 0.29 per share.

Cash & Cash Equivalents	447.86M
Total Debt	208.69M
Net Cash	239.17M
Net Cash Per Share	0.29
Equity (Book Value)	4.10B
Book Value Per Share	5.13
Working Capital	772.60M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	87.25M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 44.87%, with operating and profit margins of -19.92% and -19.75%.

Gross Margin	44.87%
Operating Margin	-19.92%
Pretax Margin	-19.70%
Profit Margin	-19.75%
EBITDA Margin	-10.34%
EBIT Margin	-19.92%
FCF Margin	n/a

Dividends & Yields

HKG:1477 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.13%
Shareholder Yield	-16.13%
Earnings Yield	-2.96%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2